Monday, 31st March 2025
To guardian.ng
Search
News  

Customs announces new policy to boost local healthcare manufacturing

By Jimisayo Opanuga
26 March 2025   |   5:01 pm
The Nigeria Customs Service (NCS) has announced a new policy to support local manufacturing of healthcare products, following President Bola Tinubu's directive. The Customs Service disclosed that under the new policy, critical raw materials needed to make pharmaceutical products, including Active Pharmaceutical Ingredients (APIs), excipients, and materials for making medicines, Long-Lasting Insecticidal Nets (LLINs), Rapid…
NCS.Photo: NSC Portal

The Nigeria Customs Service (NCS) has announced a new policy to support local manufacturing of healthcare products, following President Bola Tinubu’s directive.

The Customs Service disclosed that under the new policy, critical raw materials needed to make pharmaceutical products, including Active Pharmaceutical Ingredients (APIs), excipients, and materials for making medicines, Long-Lasting Insecticidal Nets (LLINs), Rapid Diagnostic Kits, and packaging, will be exempt from import duty and Value Added Tax (VAT) for two years.

The new policy was announced in a statemet on Wednesday throught NCS’s spokesperson, Abdullahi Maiwada.

NCS also disclosed that only pharmaceutical manufacturers recognized by the Federal Ministry of Health and Social Welfare and with a valid Tax Identification Number (TIN) will be eligible for these benefits.

This measure, according to NCS, is to ensures that the benefits directly support legitimate manufacturers committed to strengthening Nigeria’s healthcare infrastructure.

The full statement reads; “Drawing from Presidential directives aimed at enhancing local manufacturing of healthcare products, reducing the costs of medical equipment and consumables, as well as stimulating local investments, the Nigeria Customs Service (NCS) is pleased to announce that His Excellency, President Bola Ahmed Tinubu GCFR, through the Honourable Minister of Finance and Coordinating Minister of the Economy, Olawale Edun, has approved the comprehensive guidelines to actualise these objectives.

“Consequently, critical raw materials essential for the production of pharmaceutical products will be exempted from import duty and Value Added Tax (VAT) for a period of two years. This exemption covers Active Pharmaceutical Ingredients (APIs), excipients, and other vital raw materials required for manufacturing essential medicines, Long-Lasting Insecticidal Nets (LLINs), Rapid Diagnostic Kits, reagents, and packaging materials.

“To ensure that these fiscal incentives are fully utilised, eligibility is limited to manufacturers of pharmaceutical products recognised by the Federal Ministry of Health and Social Welfare, provided they possess a valid Tax Identification Number (TIN). This measure ensures that the benefits directly support legitimate manufacturers committed to strengthening Nigeria’s healthcare infrastructure.

“In commitment to transparency and effective monitoring, the NCS will compile quarterly reports detailing all importations under this policy, including data on importers, quantities, and values of the imported items, ensuring the policy’s implementation aligns with its intended objectives.

“The Nigeria Customs Service remains committed to supporting government policies while fulfilling its mandate to facilitate trade, enhance border security, and drive national development. Successful implementation of this policy requires collaboration from all stakeholders, including importers, manufacturers, and relevant government agencies. Through our collective efforts, we can achieve the shared goal of a robust healthcare sector that meets the needs of all Nigerians.”

0 Comments